[1] |
H He,N Li,Z Zhao,et al.Ischemic postconditioning improves the expression of cellular membrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction[J].Biomed Rep,2015,3(5):668-674.
|
[2] |
Balasubramanian S,Johnston RK,Moschella PC,et al.mTORin growth and protec tion of hypertrophying myocardium[J]. Cardiovasc Hematol Agents Med Chem,2009,7(1):52-63.
|
[3] |
Hwang SK,Kim HH.The functions of mTOR in ischemic diseases[J].BMB Rep,2011,44(8):506-511.
|
[4] |
Chong ZZ.mTOR:a novel therapeutic target for diseases of multiple systems[J].Curr Drug Targets,2015,16(10):1107-1132.
|
[5] |
Xia Z,Li H,Irwin MG.Myocardial ischaemia reperfusion injury:the challengeoftranslating ischaemic and anaesthetic protectionfrom animal models to humans[J].B J Anaesth,2016,117(S2):ii44-ii62.
|
[6] |
Matsui Y,Takagi H,Qu X,et al.Distinct roles of autophagy inthe heart during ischemia and reperfusion:roles of AMP-activated proteinkinase and Beclin 1 in mediating autophagy[J].Circ Res,2007,100(6):914-922.
|
[7] |
Sciarretta S,Hariharan N,Monden Y,et al.Is autophagy in response to ischemia and reperfusion protective ordetrimental for the heart?[J].Pediatr Cardiol,2011,32(3):275-281.
|
[8] |
Zoncu R,Bar-Peled L,Efeyan A,et al.mTORC1 senses lysosomal amino acids through an insideoutmechanism that requires the vacuolar H-ATPase[J].Science,2011,334(6056):678-683.
|
[9] |
Zhai P,Sciarretta S,Galeotti J,et al.Differential roles of GSK-3β during myocardial ischemia and ischemia/ reperfusion[J].Circ Res,2011,109(5):502-511.
|
[10] |
Aoyagi T,Kusakari Y,Xiao CY,et al.CardiacmTOR protects the heart against ischemia-reperfusion injury[J]. AmJPhysiol Heart Circ Physiol,2012,303(1):H75-85.
|
[11] |
Zhou Y,Fang H,Lin S,et al.Qili qiangxin protects against cardiac ischemia-reperfusion injury via activation of the mTOR pathway[J].Cell Physiol Biochem,2015,37(2):454-464.
|
[12] |
Li X,Zhang J,Huang J,et al.A Multicenter randomized double-blind parallel-group placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure[J].JAm Coll Cardiol,2013,62(12):1065-1072.
|
[13] |
Buss SJ,Muenz S,Riffel JH,et al.Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction[J].J Am Coll Cardiol,2009,54(25):2435-2446.
|
[14] |
Laplante M,Sabatini DM.Regulation of mtorc1 and its impact on gene expression at a glance[J].JCell Sci,2013,126(Pt8):1713-1719.
|
[15] |
Johnson SC,Rabinovitch PS,Kaeberlein M.Mtor is a key modulator of ageing and age-related disease[J].Nature,2013,493(7432):338-345.
|
[16] |
Takemura G,Maruyama R,Goto K,et al.Fate of isolated adultcardi omyocytes undergoing starvation-induced autophagicdegeneration[J].Autophagy,2009,5(1):90-92.
|
[17] |
Sciarretta S,Zhai P,Shao D,et al.Rheb is a critical regulator of autophagy during myocardial ischemia:pathophysiological implications in obesity and metabolic syndrome[J].Circulation,2012,125(9):1134-1146.
|
[18] |
Kerr BA,Ma L,West XZ,et al.Interference with akt signaling protects againstmyocardial infarction and death by limiting the consequences of oxidative stress[J].Sci Signal,2013,6(287):1834-1840.
|
[19] |
McLean BA,Kienesberger PC,Wang W,et al.Enhanced recovery from ischemia-reperfusion injury in pi3κzαominant negative hearts:investigating the role of alternate pi3K isoforms,increased glucose oxidation and MAPK signaling[J].JMol Cell Cardiol,2013,54:9-18.
|
[20] |
Dhingra R,Gang H,Wang Y,et al.Bidirectional regulation of nuclear factor-кB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricularmyocytes[J].Circ Heart Fail,2013,6 (2):335-343.
|
[21] |
Volkers M,Konstandin MH,Doroudgar S,et al.Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage[J].Circulation,2013,128(19):2132-2144.
|
[22] |
Mathew J,SleightP,Lonn E,etal.Reduction ofcardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril[J].Circulation,2001,104(14):1615-1621.
|
[23] |
Xu X,Hua Y,Nair S,et al.Macrophage migration inhibitory factor deletion exacerbates pressure overloadinduced cardiac hypertrophy through mitigating autophagy [J].Hypertension,2014,63(3):490-499.
|
[24] |
Chen H,Wang X,Tong M,et al.Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy[J].PLoSOne,2013,8(5):e64757.
|
[25] |
Soesanto W,Lin HY,Hu E,et al.Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats[J].Hypertension,2009,54 (6):1321-1327.
|
[26] |
Bishu K,OgutO,Kushwaha S,et al.Anti-remodeling effects of rapamycin in experimental heart failure:dose response and interaction with angiotensin receptor blockade[J].PLoS One,2013,8(12):e81325.
|
[27] |
Li MH,Zhang YJ,Yu YH,et al.Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy[J].Eur J Pharmacol,2014,728:67-76.
|